246: Vas Narasimhan on the future of pharma, plus Modernas promise & a biotech presidential bid
Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry\u2019s struggles in Washington and whether the deflated biotech sector is still overvalued. We also dive into the latest news in the life sciences, including Moderna's promise of no-cost Covid-19 vaccines and biotech entrepreneur Vivek Ramaswamy's potential run for president.